Work

O3‐06‐03: CEREBROSPINAL FLUID Aβ42 ANALYZED AS PART OF CLINICAL ROUTINE CAN ACCURATELY DISTINGUISH AMYLOID‐POSITIVE FROM AMYLOID‐NEGATIVE INDIVIDUALS